Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review
Mark Sinyor(Sunnybrook Health Science Centre), Ayal Schaffer(University of Toronto), Ari Juda(University of Toronto), Krista L. Lanctôt(Sunnybrook Health Science Centre), Anthony Levitt(University of Toronto), Celina S. Liu(Sunnybrook Health Science Centre), Abby Li(University of Toronto), Haben Y. Abraha(Sunnybrook Health Science Centre), Mahwesh Saleem(Sunnybrook Health Science Centre), Amy Cheung(Sunnybrook Health Science Centre), Christian P. Cheung(University of Guelph)
Cited by 27
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|1.1k